ICHNOS GLENMARK INNOVATION: SUBMITS IND APPLICATION TO FDA FOR ISB 2301, FIRST-IN-CLASS MULTISPECIFIC IMMUNE CELL ACTIVATOR

Reuters · 1d ago

Please log in to view news